| Sandell Scott D |
Non-Executive |
Korro Bio, Inc. (KRRO)
|
2026-03-10 |
$11.11 |
0.0% |
207,100
|
$2,300,881 |
| Sandell Scott D |
Non-Executive |
SpyGlass Pharma, Inc. (SGP)
|
2026-02-09 |
$16.00 |
0.0% |
937,500
|
$15,000,000 |
| Sandell Scott D |
Non-Executive |
MBX Biosciences, Inc. (MBX)
|
2024-09-16 |
$16.00 |
0.0% |
500,000
|
$8,000,000 |
| Sandell Scott D |
Non-Executive |
Korro Bio, Inc. (KRRO)
|
2024-04-22 |
$56.00 |
-23.7% |
17,857
|
$999,992 |
| Sandell Scott D |
Non-Executive |
Savara Inc (SVRA)
|
2023-07-17 |
$3.00 |
51.3% |
333,333
|
$999,999 |
| Sandell Scott D |
Non-Executive |
Trevi Therapeutics, Inc. (TRVI)
|
2022-04-11 |
$1.90 |
63.2% |
3,580,526
|
$6,802,999 |
| Sandell Scott D |
Non-Executive |
Bright Health Group Inc. (BHG)
|
2021-06-28 |
$115200.00 |
-100.0% |
304
|
$34,999,992 |
| Sandell Scott D |
Non-Executive |
Monte Rosa Therapeutics, Inc. (GLUE)
|
2021-06-28 |
$19.00 |
-68.4% |
1,050,000
|
$19,950,000 |
| Sandell Scott D |
Non-Executive |
Marker Therapeutics, Inc. (MRKR)
|
2021-03-16 |
$17.50 |
-82.1% |
571,428
|
$9,999,999 |
| Sandell Scott D |
Non-Executive |
Regulus Therapeutics Inc. (RGLS)
|
2020-12-04 |
$6.22 |
-74.9% |
439,860
|
$2,735,930 |
| Sandell Scott D |
Non-Executive |
Eargo, Inc. (EAR)
|
2020-10-20 |
$360.00 |
-99.3% |
15,556
|
$5,599,998 |
| Sandell Scott D |
Non-Executive |
Metacrine, Inc. (MTCR)
|
2020-09-18 |
$13.00 |
-95.5% |
769,230
|
$9,999,990 |
| Sandell Scott D |
Non-Executive |
Inozyme Pharma, Inc. (INZY)
|
2020-07-28 |
$16.00 |
-67.4% |
250,000
|
$4,000,000 |
| Sandell Scott D |
Non-Executive |
Adaptimmune Therapeutics PLC (ADAP)
|
2020-01-24 |
$0.67 |
66.5% |
7,500,000
|
$5,000,250 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-54.4% |
$-68,808,722 |
$126,390,031 |